Washington, DC (July 31, 2025) – Today, the Senate Committee on Appropriations released its Fiscal Year 2026 Labor, Health and Human Services, Education and Related Agencies funding bill. UsAgainstAlzheimer’s commends the Committee for its decisive action today in supporting increased funding for medical research and public health. These significant investments in research underscore the millions of Americans impacted by Alzheimer’s and other dementias. 

George Vradenburg, Chairman and Co-Founder of UsAgainstAlzheimer’s issued the following statement in response:

“The Senate Appropriations Committee spoke loudly today: strong investments in Alzheimer’s disease and biomedical research are a top, bipartisan priority. We thank Appropriations Committee Chair Collins and Vice Chair Murray, Subcommittee on Labor, Health and Human Services, Education and Related Agencies Chair Capito and Vice Chair Baldwin and other members of the Committee, for increasing funding in the bill for the National Institutes of Health by $400 million and for Alzheimer’s research by $100 million. With more than 7 million Americans currently living with Alzheimer’s and countless family members impacted, this funding will accelerate the search for life-changing treatments, support early detection, and strengthen critical care and support programs.

“Alzheimer’s disease remains a leading cause of death in our country, placing an immense emotional and financial burden on families and our health care system. Increased federal investment in research is essential to foster the necessary breakthroughs in prevention, diagnosis, and treatment. We thank all the advocates, scientists, caregivers, and champions who have worked tirelessly to elevate the urgency of this issue.

“We also thank the Committee for its strong support of Alzheimer’s program at the Centers for Disease Control and Prevention (CDC) and for increasing the program by $2 million.  A study released earlier this week underscores the importance of additional investments for Alzheimer’s public health programs CDC so that states and communities can work to reduce the public’s risk for developing Alzheimer’s.

“We urge the House Appropriations Committee to match the Senate in these much-needed investments for Alzheimer’s research at NIH and public health at CDC. Together, we can offer hope for a future free from the burden of this disease.”